ApoE and neurodegenerative diseases in aging

Y Yin, Z Wang - Aging and Aging-related diseases: Mechanisms and …, 2018 - Springer
Age and apolipoprotein E (ApoE) are the mightiest risk factors for dementia and
cardiovascular diseases, but the underlying mechanisms remain unclear. In human, ApoE …

Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy

CC Liu, T Kanekiyo, H Xu, G Bu - Nature Reviews Neurology, 2013 - nature.com
Abstract Apolipoprotein E (Apo-E) is a major cholesterol carrier that supports lipid transport
and injury repair in the brain. APOE polymorphic alleles are the main genetic determinants …

[HTML][HTML] Impact of apolipoprotein E isoforms on sporadic Alzheimer's disease: Beyond the role of amyloid beta

M Lozupone, F Panza - Neural Regeneration Research, 2024 - journals.lww.com
The impact of apolipoprotein E (ApoE) isoforms on sporadic Alzheimer's disease has long
been studied; however, the influences of apolipoprotein E gene (APOE) on healthy and …

Plasma levels of apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: A review

KL Rasmussen - Atherosclerosis, 2016 - Elsevier
Dementia is one of the major causes of disability in later life, and ischemic heart disease is a
leading cause of morbidity and mortality. Apolipoprotein E (apoE) plays a pivotal role in …

Apolipoprotein E and Alzheimer disease

Y Huang - Neurology, 2006 - AAN Enterprises
Apolipoprotein (apo) E, a multifunctional protein with central roles in lipid metabolism and
neurobiology, has three common isoforms (apoE2, apoE3, and apoE4) with different effects …

ApoE in Alzheimer's disease: pathophysiology and therapeutic strategies

AC Raulin, SV Doss, ZA Trottier, TC Ikezu, G Bu… - Molecular …, 2022 - Springer
Alzheimer's disease (AD) is the most common cause of dementia worldwide, and its
prevalence is rapidly increasing due to extended lifespans. Among the increasing number of …

[HTML][HTML] ApoE Cascade Hypothesis in the pathogenesis of Alzheimer's disease and related dementias

YA Martens, N Zhao, CC Liu, T Kanekiyo, AJ Yang… - Neuron, 2022 - cell.com
The ε4 allele of the apolipoprotein E gene (APOE4) is a strong genetic risk factor for
Alzheimer's disease (AD) and several other neurodegenerative conditions, including Lewy …

APOE2: protective mechanism and therapeutic implications for Alzheimer's disease

Z Li, F Shue, N Zhao, M Shinohara, G Bu - Molecular neurodegeneration, 2020 - Springer
Investigations of apolipoprotein E (APOE) gene, the major genetic risk modifier for
Alzheimer's disease (AD), have yielded significant insights into the pathogenic mechanism …

[HTML][HTML] Apolipoprotein E and Alzheimer's disease

BR Troutwine, L Hamid, CR Lysaker, TA Strope… - … Pharmaceutica Sinica B, 2022 - Elsevier
Genetic variation in apolipoprotein E (APOE) influences Alzheimer's disease (AD) risk.
APOE ε4 alleles are the strongest genetic risk factor for late onset sporadic AD. The AD risk …

Neuronal ApoE4 in Alzheimer's disease and potential therapeutic targets

L Zhang, Y Xia, Y Gui - Frontiers in aging neuroscience, 2023 - frontiersin.org
The most prevalent genetic risk factor for Alzheimer's disease (AD) is Apolipoprotein E
(ApoE), a gene located on chromosome 19 that encodes three alleles (e2, e3, and e4) that …